Listed by the USPTO as NGO, MEAGAN N
Tech Center 3700 • Art Units: 3781
This examiner grants 58% of resolved cases
NGO, MEAGAN N has resolved 218 cases, with an allowance rate of 58.3% and an interview lift of 33.7%. The median time to allowance is 1299 days. The profile shows a selective allowance result and a meaningful interview measure. Counsel may therefore consider interviews when they can clarify claim construction or support focused amendments, while retaining a complete written response strategy.
The examiner is assigned to tech center 3700 and art unit 3781. The leading companies are 3M Company, The Procter & Gamble Company, and Baxter Healthcare S.A. The leading firms are K&L Gates LLP-Chicago, BIRCH STEWART KOLASCH & BIRCH, LLP, and Bookoff McAndrews, PLLC. The company mix points to consumer, materials, and healthcare applications.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18215973 | TISSUE RESECTION SYSTEMS INCLUDING FLUID OUTFLOW MANAGEMENT | Non-Final OA | Covidien LP |
| 18852963 | METHOD AND SYSTEM FOR MONITORING A WASTE STREAM TO INCREASE EFFICIENCY OF A SURGICAL IRRIGATION PROCEDURE | Non-Final OA | CareFusion 2200, Inc. |
| 18960162 | ABSORBENT ARTICLE WITH EAR PORTION | Non-Final OA | The Procter & Gamble Company |
| 18903310 | GARMENT-LIKE NONWOVEN LAMINATES | Non-Final OA | The Procter & Gamble Company |
| 18663455 | ABSORBENT ARTICLE | Final Rejection | The Procter & Gamble Company |
| 18214548 | ABSORBENT ARTICLES WITH FRANGIBLE PATHWAYS WITH OPENING FACILITATION FEATURES | Non-Final OA | The Procter & Gamble Company |
| 18961785 | MULTI-CHAMBER BAG FOR PARENTERAL NUTRITION SOLUTIONS | Non-Final OA | Baxter Healthcare SA |
| 18962120 | MULTI-CHAMBER BAG FOR PARENTERAL NUTRITION SOLUTIONS | Non-Final OA | Baxter Healthcare SA |
| 18840808 | APPARATUS AND SYSTEM FOR MANAGING TUBING AT A TISSUE SITE | Non-Final OA | Solventum Intellectual Properties Company |
| 18537804 | LOW PROFILE DISTRIBUTION COMPONENTS FOR WOUND THERAPY | Final Rejection | Solventum Intellectual Properties Company |
| 18235453 | MULTI-LAYER ABDOMINAL CLOSURE DRESSING WITH INSTILLATION CAPABILITIES | Non-Final OA | Solventum Intellectual Properties Company |
| 18216376 | CONTOURED FOAM DRESSING SHAPED FOR PROVIDING NEGATIVE PRESSURE TO INCISIONS IN THE BREAST | Final Rejection | Solventum Intellectual Properties Company |
| 18197621 | COMPOSITE DRESSINGS FOR IMPROVED GRANULATION AND REDUCED MACERATION WITH NEGATIVE-PRESSURE TREATMENT | Non-Final OA | Solventum Intellectual Properties Company |
| 18018738 | BIORESORBABLE DRESSING FOR NEGATIVE-PRESSURE THERAPY | Non-Final OA | Solventum Intellectual Properties Company |
| 18251878 | BLOOD TRANSFER SHIELD AND METHODS OF USE | Non-Final OA | The General Hospital Corporation |
| 18179941 | MULTI-ARTICULATED CATHETERS WITH SAFETY METHODS AND SYSTEMS FOR IMAGE-GUIDED COLLABORATIVE INTRAVASCULAR DEPLOYMENT | Non-Final OA | Vanderbilt University |
| 18936047 | DELIVERY AIDS FOR GLAUCOMA SHUNTS | Non-Final OA | W. L. Gore & Associates, Inc. |
| 17610682 | SMART WIRELESSLY DRIVEN CONTACT LENS FOR MEASURING INTRAOCULAR PRESSURE OF AND TREATING GLAUCOMA PATIENTS | Final Rejection | POSTECH ACADEMY-INDUSTRY FOUNDATION |
| 18839933 | SYRINGE FOR CRYOPRESERVATION | Non-Final OA | OTSUKA PHARMACEUTICAL FACTORY, INC. |
| 18456456 | SENSOR APPARATUS SYSTEMS, DEVICES AND METHODS | Non-Final OA | DEKA Products Limited Partnership |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.3% of resolved applications examined by Meagan N Ngo were allowed (218 resolved cases), compared with 50.6% across Art Unit 3781 over the last five years.
This examiner's interview lift is +33.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Meagan N Ngo took 1,299 days on average from filing to allowance.
Meagan N Ngo examines applications in Art Unit 3781 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
